10-K Filing

HealthLynked Corp CIK: 1680139 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001213900-22-016741`
Period End Date	20211231
Filing Date	20220331
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	f10k2021_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 61 Cash Flow Statement 114 Stockholders Equity 30

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2021 and 2020, respectively	`AccountsReceivableNetCurrent`	$86.29K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2021 and 2020, respectively	`AccountsReceivableNetCurrent`	$87.15K	USD	Point-in-time
Inventory	`InventoryNet`	$134.93K	USD	Point-in-time
Inventory	`InventoryNet`	$95.20K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$137.63K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$59.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$403.54K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.65M	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $283,512 and $177,457 as of December 31, 2021 and 2020, respectively	`PropertyPlantAndEquipmentNet`	$350.48K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $283,512 and $177,457 as of December 31, 2021 and 2020, respectively	`PropertyPlantAndEquipmentNet`	$437.29K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$177.46K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$283.51K	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$151.78K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $873,417 and $151,776 as of December 31, 2021 and 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.60M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$873.42K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $873,417 and $151,776 as of December 31, 2021 and 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$4.88M	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use lease assets	`LeaseAssetsNonCurrent`	$526.73K	USD	Point-in-time
Right of use lease assets	`LeaseAssetsNonCurrent`	$417.91K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred equity compensation and deposits	`DepositsAssetsNoncurrent`	$17.94K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred equity compensation and deposits	`DepositsAssetsNoncurrent`	$138.62K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.97M	shares	Point-in-time
Total Assets	`Assets`	$10.69M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	237.89M	shares	Point-in-time
Total Assets	`Assets`	$8.03M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	237.89M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.89M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$790.84K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$89.42K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$72.84K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$288.97K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$150.25K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	-	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	$411.43K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockIssuableParValue`	$0.00	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockIssuableParValue`	$0.00	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of December 31, 2021 and 2020, respectively	`ConvertibleDebtCurrent`	$1.34M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of December 31, 2021 and 2020, respectively	`ConvertibleDebtCurrent`	-	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	719,366.00	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.15M	shares	Point-in-time
Liability-classified equity instruments, current portion	`ShortTermBankLoansAndNotesPayable`	-	USD	Point-in-time
Liability-classified equity instruments, current portion	`ShortTermBankLoansAndNotesPayable`	$61.25K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$403.47K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$701.96K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.88M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.92M	USD	Point-in-time
Government and vendor notes payable, long term portion	`NotesPayableToBankNoncurrent`	$722.51K	USD	Point-in-time
Government and vendor notes payable, long term portion	`NotesPayableToBankNoncurrent`	$450.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`OtherLongTermNotesPayable`	$101.25K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`OtherLongTermNotesPayable`	-	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$782.22K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$798.48K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$239.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$273.79K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.49M	USD	Point-in-time
Total Liabilities	`Liabilities`	$6.68M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 237,893,473 and 187,967,881 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$18.80K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 237,893,473 and 187,967,881 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`CommonStockValue`	$23.79K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of December 31, 2021 and 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 719,366 and 2,150,020 shares as of December 31, 2021 and 2020, respectively	`CommonStockIssuableValue`	$282.35K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 719,366 and 2,150,020 shares as of December 31, 2021 and 2020, respectively	`CommonStockIssuableValue`	$262.27K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$22.85M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.21M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$7.20M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$8.03M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.69M	USD	Point-in-time

Income Statement 61 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.74M	USD	Annual
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$5.76M	USD	Annual
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$767.74K	USD	Annual
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$2.42M	USD	Annual
Consulting and event revenue	`ConsultingAndEventRevenue`	$296.43K	USD	Annual
Consulting and event revenue	`ConsultingAndEventRevenue`	$432.98K	USD	Annual
Product revenue	`ProductRevenue`	$718.06K	USD	Annual
Product revenue	`ProductRevenue`	$188.59K	USD	Annual
Total revenue	`Revenues`	$6.13M	USD	Annual
Total revenue	`Revenues`	$9.20M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$3.11M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.58M	USD	Annual
Other practice operating expenses	`OperatingCostsAndExpenses`	$2.35M	USD	Annual
Other practice operating expenses	`OperatingCostsAndExpenses`	$2.15M	USD	Annual
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$2.41M	USD	Annual
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$1.02M	USD	Annual
Cost of product revenue	`CostOfRevenues`	$606.52K	USD	Annual
Cost of product revenue	`CostOfRevenues`	$146.46K	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.06M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.93M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$247.37K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$827.70K	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$9.20M	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$14.24M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-5.04M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.07M	USD	Annual
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	Annual
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-282.11K	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	Annual
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	Annual
Change in fair value of debt	`UnrealizedGainLossOnDerivatives`	$-19.25K	USD	Annual
Change in fair value of debt	`UnrealizedGainLossOnDerivatives`	$-381.83K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-530.93K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	Annual
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$739.49K	USD	Annual
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-373.66K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$75.95K	USD	Annual
Loss on settlement of litigation and other dispute	`OtherAssetImpairmentCharges`	$706.86K	USD	Annual
Interest income (expense)	`InterestIncomeexpense`	$249.76K	USD	Annual
Interest income (expense)	`InterestIncomeexpense`	$19.14K	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-2.68M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-5.37M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.41M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.76M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-5.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.41M	USD	Annual
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$446.04K	USD	Annual
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$353.57K	USD	Annual
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.77M	USD	Annual
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.20M	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	142.82M	shares	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	227.85M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	227.85M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	142.82M	shares	Annual

Cash Flow Statement 114 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-10.41M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$247.37K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$827.70K	USD	Annual
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$564.67K	USD	Annual
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$742.73K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	-	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$530.93K	USD	Annual
Loss on sales of marketable securities	`GainLossOnInvestments`	-	USD	Annual
Loss on sales of marketable securities	`GainLossOnInvestments`	$-282.11K	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$739.49K	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	Annual
Change in fair value of debt	`NoncashExpense`	$19.25K	USD	Annual
Change in fair value of debt	`NoncashExpense`	$381.83K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$75.95K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-373.66K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-86.30K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-866.00	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$24.74K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$39.73K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-73.12K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$48.06K	USD	Annual
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$222.78K	USD	Annual
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$109.59K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-169.59K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$983.90K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$114.25K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$221.01K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$46.37K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	-	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-16.59K	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-67.61K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.12M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.77M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.78M	USD	Annual
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$810.16K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$322.11K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$137.39K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.25K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.00K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.81M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-341.36K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.19M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.95M	USD	Annual
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	Annual
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$350.20K	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.88M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	$149.00K	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	-	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$967.76K	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Proceeds from government loans	`ProceedsFromGovernmentLoans`	$1.07M	USD	Annual
Proceeds from government loans	`ProceedsFromGovernmentLoans`	-	USD	Annual
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	$51.11K	USD	Annual
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	$27.89K	USD	Annual
Repurchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$7.70K	USD	Annual
Repurchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.24M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$356.80K	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$51.74K	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.13M	USD	Annual
Cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$162.18K	USD	Point-in-time
Cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$162.18K	USD	Point-in-time
Cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.29M	USD	Point-in-time
Cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$203.40K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	-	USD	Annual
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	$632.83K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$262.27K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$43.24K	USD	Annual
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.67M	USD	Annual
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	Annual
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	Annual
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	-	USD	Annual
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	$366.30K	USD	Annual
Fair value of liability-classified equity instruments issued	`FairValueOfLiabilityclassifiedEquityInstrumentsIssued`	-	USD	Annual
Fair value of liability-classified equity instruments issued	`FairValueOfLiabilityclassifiedEquityInstrumentsIssued`	$165.00K	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	-	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	-	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$365.56K	USD	Annual
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	-	USD	Annual
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$2.91M	USD	Annual
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	-	USD	Annual
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$2.00M	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	-	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$328.00K	USD	Annual
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	-	USD	Annual
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$135.30K	USD	Annual
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	Annual
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	Annual
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceived`	-	USD	Annual
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceived`	$3.01M	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	-	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	$283.86K	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	Annual
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$4.77M	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$2.18M	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$186.28K	USD	Annual
Sale of common and preferred stock in exchange for marketable securities	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$3.07M	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.67M	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	Annual
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	Annual
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$43.23K	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`StockIssuedDuringPeriodValueOther`	$283.86K	USD	Annual
Acquisition of Cura Health Management LLC	`AcquisitionOfCuraHealthManagementLLC`	$201.68K	USD	Annual
Acquisition of MedOffice Direct LLC	`AcquisitionOfMedOfficeDirectLLC`	$2.70M	USD	Annual
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueAcquisitions`	$292.78K	USD	Annual
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueAcquisitions`	$366.30K	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	-	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	$947.97K	USD	Annual
Exercise of stock options	`ExerciseOfStockOptionsValue`	$16.45K	USD	Annual
Repurchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$7.70K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$487.28K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$313.87K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$231.60K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$200.97K	USD	Annual
Net loss	`ProfitLoss`	$-5.76M	USD	Annual
Net loss	`ProfitLoss`	$-10.41M	USD	Annual
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.